Neuronal Na+/K+ ATPase is an autoantibody target in paraneoplastic neurologic syndrome

Neurology

Volumn 84, Issue 16, 2015, Pages 1673-1679

  Scharf, Madeleine ^a   Miske, Ramona ^a   Heidenreich, Fedor ^b   Giess, Ralf ^b   Landwehr, Peter ^b   Blöcker, Inga Madeleine ^a   Begemann, Nora ^a   Denno, Yvonne ^a   Tiede, Stephan ^a   Dähnrich, Cornelia ^a   Schlumberger, Wolfgang ^a   Unger, Mandy ^a   Teegen, Bianca ^a   Stöcker, Winfried ^a   Probst, Christian ^a   Komorowski, Lars ^a  

^a Institute of Experimental Immunology   (Germany)

^b Henriettenstiftung   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AUTOANTIBODY; AUTOANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; ATP1A3 PROTEIN, HUMAN;

AGED; ANTIGEN PURIFICATION; ARTICLE; ATAXIA; BRAIN STEM; CASE REPORT; CEREBROSPINAL FLUID; COLON ADENOCARCINOMA; COMPETITIVE INHIBITION; DRUG MEGADOSE; DYSARTHRIA; DYSPHAGIA; EPITOPE MAPPING; FEMALE; GAZE PARALYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MASS SPECTROMETRY; NERVOUS TISSUE; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; QUADRIPLEGIA; VISION; VISUAL IMPAIRMENT; ADENOCARCINOMA; BLOOD; COLON TUMOR; HEK293 CELL LINE; IMMUNOLOGY; NERVE CELL; PATHOPHYSIOLOGY;

ADENOCARCINOMA; AGED; ATAXIA; AUTOANTIBODIES; COLONIC NEOPLASMS; FEMALE; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN G; NEURONS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84928139476     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001493     Document Type: Article

References (19)

1. Probst C, Saschenbrecker S, Stöcker W, Komorowski L. Anti-neuronal autoantibodies: current diagnostic challenges. Mult Scler Relat Disord 2014;3:304-320.
2. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202:473-477.
3. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7: 1091-1098.
4. Boronat A, Gelfand JM, Gresa-Arribas N, et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol 2013; 73:120-128.
5. Sabater L, Gaig C, Gelpi E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 2014;13:575-586.
6. Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014;13:276-286.
7. Stöcker W, Otte M, Ulrich S, et al. Autoimmunity to pancreatic juice in Crohn's disease: results of an autoantibody screening in patients with chronic inflammatory bowel disease. Scand J Gastroenterol Suppl 1987;139: 41-52.
8. Sverdlov ED, Akopyanz NS, Petrukhin KE, Broude NE, Monastyrskaya GS, Modyanov NN. Na1,K1-ATPase: tissue-specific expression of genes coding for alphasubunit in diverse human tissues. FEBS Lett 1988;239: 65-68.
9. Heo S, Csaszar E, Jung G, Beuk T, Hoger H, Lubec G. Hippocampal levels and activity of the sodium/potassium transporting ATPase subunit alpha-3 (AT1A3) are paralleling memory training in the multiple T-maze in the C57BL/6J mouse. Neurochem Int 2012;61:702-712.
10. Forrest MD, Wall MJ, Press DA, Feng J. The sodiumpotassium pump controls the intrinsic firing of the cerebellar Purkinje neuron. PLoS One 2012;7:e51169.
11. Baba A, Yoshikawa T, Ogawa S. Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002;40: 1153-1159.
12. Vicco MH, Ferini F, Rodeles L, et al. Assessment of crossreactive host-pathogen antibodies in patients with different stages of chronic Chagas disease. Rev Esp Cardiol 2013; 66:791-796.
13. Heinzen EL, Swoboda KJ, Hitomi Y, et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet 2012;44:1030-1034.
14. de Carvalho AP, Sweadner KJ, Penniston JT, et al. Mutations in the Na1/K1-ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 2004;43:169-175.
15. Demos MK, van Karnebeek CD, Ross CJ, et al. A novel recurrent mutation in ATP1A3 causes CAPOS syndrome. Orphanet J Rare Dis 2014;9:15.
16. Brashear A, Ozelius LJ, Sweadner KJ. ATP1A3 mutations: what is the phenotype? Neurology 2014;82:468-469.
17. Hutchinson M, Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 2008;71:1291-1292.
18. Sakai H, Suzuki T, Maeda M, et al. Up-regulation of Na(1),K(1)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer. FEBS Lett 2004;563:151-154.
19. Shibuya K, Fukuoka J, Fujii T, et al. Increase in ouabainsensitive K1-ATPase activity in hepatocellular carcinoma by overexpression of Na1, K1-ATPase alpha 3-isoform. Eur J Pharmacol 2010;638:42-46.